Evidence map›Paper›PMID 29725654›Full record

ArticleKidney international reports2018

Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.

Lena Berchtold, Gilbert Zanetta, Karine Dahan, Fabrice Mihout, Julie Peltier, Dominique Guerrot, Isabelle Brochériou, Pierre Ronco, Hanna Debiec

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. The Role of Anti-PLAInternational journal of environmental research and public health · 2022
    Review
  8. Article
  9. Advances in Membranous Nephropathy.Journal of clinical medicine · 2021
    Review
  10. Article
  11. Article
  12. Membranous nephropathy.Jornal brasileiro de nefrologia
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lena BerchtoldInserm, UMR_S 1155, Paris, France.
Gilbert ZanettaDepartment of Nephrology, Dijon University Hospital, Dijon, France.
Karine DahanDepartment of Nephrology and Dialysis, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France.
Fabrice MihoutDepartment of Nephrology and Dialysis, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France.
Julie PeltierDepartment of Renal Intensive Care Unit and Kidney Transplantation, AP-HP, Tenon Hospital, Paris, France.
Dominique GuerrotDepartment of Nephrology, Rouen University Hospital, Normandie University, Université de Rouen, Inserm U1096, Rouen, France.
Isabelle BrochériouDepartment of Pathology, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France.
Pierre RoncoInserm, UMR_S 1155, Paris, France.
Hanna DebiecInserm, UMR_S 1155, Paris, France.

Funding

European Research Council 322947
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29725654
PMCPMC5932116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.